Recipient of the American Pharmacist Association’s Generation Rx Award of Excellence. The 2022 recipient was Heidi Eukel, PharmD, a faculty member at North Dakota State University and ONE Program team member, in recognition of her commitment to the mission of substance abuse education
Recipient of the 2020 Research in Social and Administrative Pharmacy journal’s 2020 Best Paper Award for the paper, “Program evaluation of the Opioid Naloxone Education (ONE Rx) program using the RE-AIM model.” This award is decided by a panel of judges from the RSAP editorial advisory board and is aimed to reflect the mission of the journal; methodologically rigorous and theory-driven research in the social/behavioral pharmaceutical sciences that appeals to our entire international audience. The award carries much esteem in academic circles.
Strand M, Eukel H, Frenzel O, Skoy E, Steig J, Werremeyer A. Program Evaluation of the Opioid and Naloxone Education (ONE Rx) Program Using the RE-AIM Model. Research in Social and Administrative Pharmacy. 2020;16:1248-1254. https://doi.org/10.1016/j.
Recipient of the 2019 Public Health Publication Award from the American Association of Colleges of Pharmacy (AACP), Public Health Special Interest Group, July 14, 2019, Chicago, IL. The paper: “Moving opioid misuse prevention upstream: A pilot study of community pharmacists screening for opioid misuse risk.” Strand MA, Eukel H, Burck S. in Research in Social and Administrative Pharmacy. 2019;15:1032-1036. doi: 10.1016/j.sapharm.2018.07.011
Recipient of the United States Public Health Service “Excellence in Public Health Pharmacy Award.” The recipient was Siri Burck, research assistant, and third-year NDSU School of Pharmacy student Siri, in recognition of our work to design an opioid misuse prevention toolkit for pharmacists to use for opioid misuse prevention in the community pharmacy. April 11, 2018 at NDSU, Fargo, ND.
Community Pharmacy Based Screening & Interventions For Opioid Misuse and Accidental Overdose
This is a recording of a virtual poster session presented at the 2020 AMERSA (The Association for Multidisciplinary Education and Research in Substance use and Addiction) conference. It provides an overview of the project and results from October 2018 to June 2020.
Community Pharmacist Prevention of Opioid Misuse and Accidental Overdose Through Stigma Reduction
Presentation of a poster originally presented at fall 2019 AATOD conference highlighting the impact on pharmacist stigma toward OUD of a training designed to coach pharmacists to partner with their patients using the ONE Program model.
Examining Attitudes and Behaviors that Inhibit Pharmacist Implementation of the ONE Program
This short presentation provides an overview of a paper published in Innovations in Pharmacy . It uses the theory of planned behavior to determine what attitudes and beliefs contribute to unsuccessful implementation of opioid risk screening.
Patient Experience & Perception of a Community-Pharmacy Program to Reduce Opioid-Related Harm
This poster presentation from the 2021 North Dakota Pharmacy Convention discussed the patient experience with and perception of the ONE Program process and the patient impact of the screening and interventions offered by pharmacists.
Evaluation of an opioid misuse prevention program in community pharmacies using the RE-AIM model
This short presentation provides an overview of poster shared at the 2020 virtual annual meeting of the American Public Health Association. It uses the RE-AIM model to evaluate the rollout of the ONE Program in North Dakota community pharmacies.
RE-AIM Model to Evaluate the ONE Program Impact – A Public Health Series Presentation
This presentation from Dr. Mark Strand for the NDSU Public Health Series uses the RE-AIM model to answer the question “Are we having the impact we think we are?”